Skip to main content
Caplight Logo









Wobble Genomics

Wobble Genomics

Private
EdinburghHealthcare & Life Scienceshttps://www.wobblegenomics.com/

Last Round

Series A

Mar 7, 2024

Total Funding Raised

$13.76M

Company Overview

Wobble Genomics is a biotechnology company that specializes in long-read RNA sequencing and the discovery of novel nucleic acid biomarkers to improve cancer diagnostics and therapy selection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

RNA sequencinglong-read sequencingtranscriptomicsRNA modificationfull-length transcriptsbioinformaticsdrug discoverybiomarker identificationnext-gen sequencingNGSRNA isoform analysisgenomics platformbiotech R&Dsingle-molecule sequencingspatial transcriptomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wobble Genomics Comparables

Compare Wobble Genomics with similar companies based on industry and business-model similarity.

Wobble Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alida Biosciences
81%
Alithea Genomics
77%
DirectSeq Biosciences, Inc.
77%

Wobble Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 7, 2024
Seed RoundJan 5, 2024
SeedSep 2, 2021

Key People

Founding team and executive leadership

Richard Kuo

CEO, Founder

Founding Team

Wobble Genomics Investors

Notable investors and investment history

Wobble Genomics investors
InvestorRounds
BGFSeries A
Mercia VenturesSeries A
IQ CapitalSeries A
Old College CapitalSeries A, Seed
Eos AdvisorySeries A, Seed
Mercia VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Presenting new data on mRNA sequencing for ADC therapy selection at AACR Annual Meeting 2026.

  • Apr 15, 2026

    Monthly visitors increased 42% MoM.

Wobble Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wobble Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wobble Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range19
Year Founded2020
Last FundingMar 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?